<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>27838349</identifier>
<setSpec>1885-5857</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Cladellas, Mercè</dc:author>
<dc:author>Ivern, Consol</dc:author>
<dc:author>Recasens, Lluis</dc:author>
<dc:author>Poveda, Paula</dc:author>
<dc:author>Comín-Colet, Josep</dc:author>
<dc:author>Bazán, Víctor</dc:author>
<dc:author>García-García, Cosme</dc:author>
<dc:author>Ribas-Barquet, Núria</dc:author>
<dc:author>Vila, Joan</dc:author>
<dc:author>Enjuanes, Cristina</dc:author>
<dc:author>Meroño, Oona</dc:author>
<dc:author>Orient, Salvador</dc:author>
<dc:description xml:lang="en">BACKGROUND AND OBJECTIVES Iron deficiency (ID) is a prevalent condition in patients with ischemic heart disease and heart failure. Little is known about the impact of ID on exercise capacity and quality of life (QoL) in the recovery phase after an acute coronary syndrome (ACS). METHODS Iron status and its impact on exercise capacity and QoL were prospectively evaluated in 244 patients 30 days after the ACS. QoL was assessed by the standard EuroQoL-5 dimensions, EuroQoL visual analogue scale, and Heart-QoL questionnaires. Exercise capacity was analyzed by treadmill/6-minute walk tests. The effect of ID on cardiovascular mortality and readmission rate was also investigated. RESULTS A total of 46% of the patients had ID. These patients had lower exercise times (366±162 vs 462±155seconds; P&lt;.001), metabolic consumption rates (7.9±2.9 vs 9.3±2.6 METS; P=.003), and EuroQoL-5 dimensions (0.76±0.25 vs 0.84±0.16), visual analogue scale (66±16 vs 72±17), and Heart-QoL (1.9±0.6 vs 2.2±0.6) scores (P&lt;.05). ID independently predicted lower exercise times (OR, 2.9; 95%CI, 1.1-7.6; P=.023) and worse QoL (OR, 1.9; 95%CI, 1.1-3.3; P&lt;.001) but had no effect on cardiovascular morbidity or mortality. CONCLUSIONS ID, a prevalent condition in ACS patients, results in a poorer mid-term functional recovery, as measured by exercise capacity and QoL.</dc:description>
<dc:type>Journal Article</dc:type>
<dc:language>es</dc:language>
<dc:subject>Inflamación</dc:subject>
<dc:subject>Capacidad de esfuerzo</dc:subject>
<dc:subject>Síndrome coronario agudo</dc:subject>
<dc:subject>Déficit de hierro</dc:subject>
<dc:subject>Inflammation</dc:subject>
<dc:subject>Acute coronary syndrome</dc:subject>
<dc:subject>Calidad de vida</dc:subject>
<dc:subject>Exercise capacity</dc:subject>
<dc:subject>Iron deficiency</dc:subject>
<dc:subject>Capacidad funcional</dc:subject>
<dc:subject>Functional capacity</dc:subject>
<dc:subject>Quality of life</dc:subject>
<dc:date>2017 May </dc:date>
<dc:title xml:lang="en">Iron Deficiency Is a Determinant of Functional Capacity and Health-related Quality of Life 30 Days After an Acute Coronary Syndrome.</dc:title>
<dc:publisher>Revista espanola de cardiologia (English ed.)</dc:publisher>
</metadata>
</record>
</pubmed-document>
